6-Thioguanine: A naked bullet? (or how pharmacogenomics can make old drugs brand new)

被引：10

作者：

Baert, F ^{[1
]}

Rutgeerts, P ^{[1
]}

机构：

[1] Univ Hosp Gasthuisberg, Dept Internal Med, B-3000 Louvain, Belgium

来源：

INFLAMMATORY BOWEL DISEASES | 2001年 / 7卷 / 03期

关键词：

D O I：

10.1097/00054725-200108000-00002

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：190 / 191

页数：2

共 10 条

[1] Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy [J].

Colombel, JF ;

Ferrari, N ;

Debuysere, H ;

Marteau, P ;

Gendre, JP ;

Bonaz, B ;

Soulé, JC ;

Modgliani, R ;

Touze, Y ;

Catala, P ;

Libersa, C ;

Broly, F .

GASTROENTEROLOGY, 2000, 118 (06) :1025-1030

[2] Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy [J].

Cuffari, C ;

Hunt, S ;

Bayless, TM .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (08) :1009-1014

[3] Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease [J].

Dubinsky, MC ;

Lamothe, S ;

Yang, HY ;

Targan, SR ;

Sinnett, D ;

Théorêt, Y ;

Seidman, EG .

GASTROENTEROLOGY, 2000, 118 (04) :705-713

[4] An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy [J].

Dubinsky, MC ;

Hassard, PV ;

Seidman, EG ;

Kam, LY ;

Abreu, MT ;

Targan, SR ;

Vasiliauskas, EA .

INFLAMMATORY BOWEL DISEASES, 2001, 7 (03) :181-189

[5]

DUBINSKY MC, 2000, GASTROENTEROLOGY, V118, pA4926

[6] Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: Implications for drug monitoring in children with acute lymphoblastic leukemia [J].

Innocenti, F ;

Danesi, R ;

Favre, C ;

Nardi, M ;

Menconi, MC ;

Di Paolo, A ;

Bocci, G ;

Fogli, S ;

Barbara, C ;

Barachini, S ;

Casazza, G ;

Macchia, P ;

Del Tacca, M .

THERAPEUTIC DRUG MONITORING, 2000, 22 (04) :375-382

[7] Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma [J].

Lewis, JD ;

Schwartz, JS ;

Lichtenstein, GR .

GASTROENTEROLOGY, 2000, 118 (06) :1018-1024

[8]

RELLING MV, 1999, J NATL CANCER I, V91, P1983

[9]

Thomsen JB, 1999, CANCER-AM CANCER SOC, V86, P1080, DOI 10.1002/(SICI)1097-0142(19990915)86:6<1080::AID-CNCR26>3.0.CO

[10]

2-5

← 1 →